Cabaletta Bio, Inc. Liquidation Value
CABA
Other
Cash & Equivalents
$82.98M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $82.98M
Total Obligations: -$77.25M
$5.73M
Per share: $0.06
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $82.98M
AR: $0
Total Obligations: -$77.25M
$5.73M
Per share: $0.06
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $82.98M
AR: $0
Inventory: $0
Total Obligations: -$77.25M
$5.73M
Per share: $0.06
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $5.73M | $0.06 |
| Liquid Liquidation Value | $5.73M | $0.06 |
| Operating Liquidation Value | $5.73M | $0.06 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $82.98M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $50.15M |
| Long-term Debt | N/A |
| Op. Lease Liability | $3.46M |
| Finance Lease | $23.64M |
| Shares Outstanding | 100.5M |
Explore all 150 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $82.98M | N/A | N/A | $6.64M | $50.15M | N/A | $3.46M | $23.64M |
| 2025-09-30 | $60.21M | N/A | N/A | $8.27M | $45.73M | N/A | $3.63M | $22.15M |
| 2025-06-30 | $145.61M | N/A | N/A | $7.19M | $41.54M | N/A | $4.57M | $20.33M |
| 2025-03-31 | $131.83M | N/A | N/A | $6.49M | $33.99M | N/A | $5.48M | $23.31M |
| 2024-12-31 | $163.96M | N/A | N/A | $4.92M | $27.09M | N/A | $6.37M | $9.23M |
| 2024-09-30 | $170.61M | N/A | N/A | $2.18M | $22.88M | N/A | $15.22M | N/A |
| 2024-06-30 | $178.61M | N/A | N/A | $4.22M | $17.90M | N/A | $7.40M | N/A |
| 2024-03-31 | $175.29M | N/A | N/A | $5.84M | $17.97M | N/A | $8.17M | N/A |
▼ Community Notes